Chrystal U. Louis

6.6k citations

56 papers · 4.6k indexed · 4 hit papers · h-index 20

Oncology top 0.5%
Immunology top 2%
Molecular Biology top 10%
Genetics top 2%
Neurology top 1%

Co-authors: Nabil Ahmed Daniel W. Lee Rebecca Gardner Stephan A. Grupp Michael C. Jensen David Porter Crystal L. Mackall Jason M. Shohet
Topics: CAR-T cell therapy research (18 papers)Neuroblastoma Research and Treatments (16 papers)Virus-based gene therapy research (10 papers)
Cited by: Oncology Immunology Neurology
Journals: New England Journal of Medicine Nature Medicine Journal of Clinical Oncology
Partner nations: United States Italy Australia

In The Last Decade

Chrystal U. Louis

52 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Current concepts in the diagnosis and management of cytokine release syndrome

2014 1.9k citations Chrystal U. Louis, Nabil Ahmed et al. profile →
Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma

2011 882 citations Chrystal U. Louis, Barbara Savoldo et al. profile →
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma

2017 391 citations Andras Heczey, Chrystal U. Louis et al. Molecular Therapy profile →
Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma

2025 14 citations Sandhya Sharma, Andras Heczey et al. Nature Medicine profile →

Peers

Countries citing papers authored by Chrystal U. Louis

Since Specialization

Citations

This map shows the geographic impact of Chrystal U. Louis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chrystal U. Louis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chrystal U. Louis more than expected).

Fields of papers citing papers by Chrystal U. Louis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chrystal U. Louis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chrystal U. Louis. The network helps show where Chrystal U. Louis may publish in the future.

Co-authorship network of co-authors of Chrystal U. Louis

This figure shows the co-authorship network connecting the top 25 collaborators of Chrystal U. Louis. A scholar is included among the top collaborators of Chrystal U. Louis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chrystal U. Louis. Chrystal U. Louis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TSC-100 and TSC-101 Demonstrate the Potential to Reduce Relapse Rates and Increase Relapse-Free Survival in Patients with AML, ALL, or MDS Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT) with Reduced Intensity Conditioning (RIC): Preliminary Results from the Phase 1 Alloha Trial (NCT05473910) 2025 ·Transplantation and Cellular Therapy ·Monzr M. Al Malki,Alla Keyzner,(unknown),Yibin Chen,Hyung C. Suh,Tania Jain,Melhem Solh,Anson Snow,Luis Piñeiro,Saar Gill,Lohith Gowda,Joseph P. Uberti,Timothy P. White,Yun Wang,Cuong V. Nguyen,Chrystal U. Louis,Shrikanta Chattopadhyay,Michelle Matzko,Ran Reshef	0
2	Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastomabreakdown → 2025 ·Nature Medicine ·(unknown),Sandhya Sharma,Andras Heczey,Mae Woods,(unknown),Chrystal U. Louis,Bambi Grilley,Sachin G. Thakkar,Meng-Fen Wu,Tao Wang,Cliona M. Rooney,Malcolm K. Brenner,Helen E. Heslop	14
3	Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee 2024 ·Cytotherapy ·(unknown),Gabriela Marón,Allistair Abraham,Alice Bertaina,Senthil Velan Bhoopalan,(unknown),Carmem Bonfim,(unknown),Amy E. DeZern,Jingjing Li,Chrystal U. Louis,Joseph H. Oved,Mara Pavel-Dinu,Duncan Purtill,Annalisa Ruggeri,(unknown),Robert Wynn,Jaap Jan Boelens,Susan E. Prockop,Akshay Sharma	4
4	International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant 2023 ·Cytotherapy ·(unknown),Allistair Abraham,Alice Bertaina,Senthil Velan Bhoopalan,Carmem Bonfim,Sandra Cohen,Amy E. DeZern,Chrystal U. Louis,Joseph H. Oved,Mara Pavel-Dinu,Duncan Purtill,Annalisa Ruggeri,(unknown),Akshay Sharma,Robert Wynn,Jaap Jan Boelens,Susan E. Prockop	2
5	Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer 2019 ·Frontiers in Oncology ·Jonathan W. Goldman,David Waterhouse,Ben George,Peter J. O’Dwyer,Rafia Bhore,(unknown),(unknown),Chrystal U. Louis,Teng Jin Ong,Karen Kelly	12
6	Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer 2018 ·Clinical Cancer Research ·(unknown),Emily A. Pace,Sharlene Adams,Michael D. Curley,Victoria Rimkunas,Lin Nie,(unknown),Troy Bloom,Sergio Iadevaia,Jason Baum,(unknown),Akos Czibere,Chrystal U. Louis,Daryl C. Drummond,Ulrik B. Nielsen,Birgit Schoeberl,J. Marc Pipas,Robert M. Straubinger,Vasileios Askoxylakis,Alexey A. Lugovskoy	44
7	A phase 1/2 study of metronomic 5-fluorouracil (5-FU) plus nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with metastatic pancreatic cancer 2017 ·Annals of Oncology ·Vincent J. Picozzi,Vaibhav Sahai,Diane M. Simeone,(unknown),Allyson J. Ocean,Philip Philip,(unknown),Aparna Kalyan,Michael S. Ondovik,(unknown),Chrystal U. Louis	1
8	Relative contribution of baseline variables in a nomogram to predict survival in patients treated with nab-paclitaxel plus gemcitabine or gemcitabine alone for metastatic pancreatic cancer 2017 ·Annals of Oncology ·David Goldstein,Daniel D. Von Hoff,Elena G. Chiorean,Michele Reni,Josep Tabernero,Ramesh K. Ramanathan,Julia Wilkerson,Marc Botteman,(unknown),(unknown),Brian Lu,Chrystal U. Louis,Markus F. Renschler,(unknown),Chee Khoon Lee	0
9	CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastomabreakdown → 2017 ·Molecular Therapy ·Andras Heczey,Chrystal U. Louis,Barbara Savoldo,Olga Dakhova,April Durett,Bambi Grilley,Hao Liu,(unknown),Zhuyong Mei,Adrian P. Gee,Birju Mehta,Huimin Zhang,Nadia Mahmood,Haruko Tashiro,Helen E. Heslop,Gianpietro Dotti,Cliona M. Rooney,Malcolm K. Brenner	391
10	TG4010 Immunotherapy Combined with First-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC). Phase 2B Results of the Time Study 2015 ·Annals of Oncology ·Élisabeth Quoix,John Nemunaitis,Zsolt Pápai,H. Léna,Dominique Genet,Chrystal U. Louis,Manuel Cobo,(unknown),(unknown),Jean‐Marc Limacher	1
11	Cellular immunotherapy for pediatric solid tumors 2014 ·Cytotherapy ·Meenakshi Hegde,(unknown),Tiara T. Byrd,Chrystal U. Louis,Nabil Ahmed	13
12	Radiation Therapy to the Primary and Postinduction Chemotherapy MIBG-Avid Sites in High-Risk Neuroblastoma 2014 ·International Journal of Radiation OncologyBiologyPhysics ·Ali Mazloom,Chrystal U. Louis,Jed G. Nuchtern,Eugene S. Kim,Heidi V. Russell,Wendy Allen‐Rhoades,Robert A. Krance,Arnold C. Paulino	35
13	Congenital Neuroblastoma in a Neonate With Isotretinoin Embryopathy 2013 ·Journal of Pediatric Hematology/Oncology ·(unknown),Chrystal U. Louis,John Hicks,Peter E. Zage,Heidi V. Russell	3
14	Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma 2010 ·Journal of Immunotherapy ·Chrystal U. Louis,Karin Straathof,Catherine M. Bollard,(unknown),Claudia Gerken,Teresita Lopez,M. Helen Huls,Andrea M. Sheehan,Meng-Fen Wu,(unknown),Adrian P. Gee,Malcolm K. Brenner,Cliona M. Rooney,Helen E. Heslop,Stephen Gottschalk	160
15	Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression 2009 ·Molecular Therapy ·Nabil Ahmed,Vita S. Salsman,Eric Yvon,Chrystal U. Louis,László Perlaky,Winfried S. Wels,(unknown),(unknown),Martin Pulé,Cliona M. Rooney,Helen E. Heslop,Stephen Gottschalk	167
16	Cellular Immunotherapy for Neuroblastoma: A Review of Current Vaccine and Adoptive T Cell Therapeutics 2009 ·Current Pharmaceutical Design ·Chrystal U. Louis,M.K. Brenner	13
17	244: Treatment of Epstein Barr Virus Positive Nasopharyngeal Carcinoma with Adoptively Transferred Cytotoxic T Lymphocytes 2008 ·Biology of Blood and Marrow Transplantation ·Chrystal U. Louis,Karin Straathof,Claudia Gerken,(unknown),(unknown),Teresita Lopez,Catherine M. Bollard,Mary V. Gresik,Heidi L. Weiss,Adrian P. Gee,Malcolm K. Brenner,Cliona M. Rooney,Helen E. Heslop,Stephen Gottschalk	1
18	High blood pressure and hypertension in children with newly diagnosed acute leukemia and lymphoma 2008 ·Pediatric Nephrology ·Chrystal U. Louis,Lavjay Butani	13
19	T Cell Therapies 2007 ·PubMed ·Stephen Gottschalk,Catherine M. Bollard,Karin Straathof,Chrystal U. Louis,Barbara Savoldo,Gianpietro Dotti,M.K. Brenner,HE Heslop,Cliona M. Rooney	11
20	Observer Disagreement in Rating Neurologic Impairment in Multiple Sclerosis: Facts and Consequences 1991 ·European Neurology ·M H Verdier-Taillefer,(unknown),O Lyon-Caen,M. Clanet,Olivier Gout,Chrystal U. Louis,Annick Alpérovitch	23

About Chrystal U. Louis

Chrystal U. Louis is a scholar working on Oncology, Neurology and Cancer Research, having authored 56 papers that have together received 4.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (18 papers), Neuroblastoma Research and Treatments (16 papers) and Virus-based gene therapy research (10 papers). The work is most often cited by research in Oncology (3.5k citations), Immunology (1.3k citations) and Neurology (819 citations). Chrystal U. Louis has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Nabil Ahmed, Daniel W. Lee, Rebecca Gardner, Stephan A. Grupp, Michael C. Jensen, David Porter, Crystal L. Mackall, Jason M. Shohet, Helen E. Heslop and Cliona M. Rooney. Their work appears in journals such as New England Journal of Medicine, Nature Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact